Inotiv, Inc. (NOTV)
| Market Cap | 79.41M |
| Revenue (ttm) | 582.15M |
| Net Income (ttm) | -339.63M |
| Shares Out | 25.78M |
| EPS (ttm) | -13.69 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 68,363 |
| Open | 3.14 |
| Previous Close | 3.10 |
| Day's Range | 3.08 - 3.18 |
| 52-Week Range | 2.90 - 23.37 |
| Beta | 2.44 |
| Analysts | Buy |
| Price Target | 9.00 (+192.21%) |
| Earnings Date | Aug 10, 2023 |
About NOTV
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment, Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial p... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for NOTV stock is "Buy." The 12-month stock price forecast is $9.0, which is an increase of 192.21% from the latest price.
News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inotiv, Inc. - NOTV
NEW YORK , Sept. 29, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. ("Xylem" or the "Company") (NASDAQ: NOTV).
Inotiv Announces the Sale of its Israeli Businesses to Harlan Holdings Ltd.
WEST LAFAYETTE, Ind., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...
Inotiv, Inc. to Participate in Upcoming September 2023 Investor Conferences
WEST LAFAYETTE, Ind., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...
Inotiv, Inc. (NOTV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK , Aug. 15, 2023 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inotiv, Inc. ("Inotiv" or "the Company"...
Inotiv Reports Third Quarter Financial Results for Fiscal 2023 and Provides Business Update
WEST LAFAYETTE, Ind., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...
Inotiv, Inc. to Report Fiscal 2023 Third Quarter Financial Results and Host Conference Call on Thursday, August 10, 2023
WEST LAFAYETTE, Ind., July 24, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...
Inotiv, Inc. to Present at Jefferies 2023 Healthcare Conference
WEST LAFAYETTE, Ind., May 25, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and an...
Inotiv, Inc. to Participate in May Investor Conferences
WEST LAFAYETTE, Ind., May 19, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and an...
Inotiv, Inc. Expands Safety Pharmacology Offering to Include Cardiopulmonary Telemetry
WEST LAFAYETTE, Ind., May 04, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development s...
Inotiv, Inc. to Report Fiscal 2023 Second Quarter Financial Results and Host Conference Call on Thursday, May 11, 2023
WEST LAFAYETTE, Ind., April 26, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and ...
Inotiv, Inc. Announces First Quarter Fiscal 2023 Financial Results
Reiterates Select Full Year Fiscal 2023 Financial Guidance Reiterates Select Full Year Fiscal 2023 Financial Guidance
Inotiv, Inc. to Report Fiscal 2023 First Quarter Financial Results and Host Conference Call on Monday, February 13, 2023
WEST LAFAYETTE, Ind., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...
Inotiv Selected as a Winner of the 2023 Top Workplaces USA Award
WEST LAFAYETTE, Ind., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...
Inotiv, Inc. Announces Changes to Board of Directors
WEST LAFAYETTE, Ind., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...
Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2022 Financial Results
Provides Select First Quarter and Full Year Fiscal 2023 Financial Guidance Provides Select First Quarter and Full Year Fiscal 2023 Financial Guidance
Inotiv, Inc. to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results and Host Conference Call on Tuesday, January 10, 2023
WEST LAFAYETTE, Ind., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...
Inotiv Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
Boston, Massachusetts--(Newsfile Corp. - December 28, 2022) - Block & Leviton is investigating Inotiv, Inc. (NASDAQ: NOTV) for potential securities law violations. Investors who have lost money in the...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inotiv, Inc. - NOTV
New York, New York--(Newsfile Corp. - December 17, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. ("Inotiv" or the "Company") (NASDAQ: NOTV). Such investors are a...
Inotiv, Inc. Provides Business Update and Select Preliminary Fiscal Year 2022 Financial Results
Delays Release of Full Financial Results for the Fourth Quarter and Fiscal Year Ended September 30, 2022 Delays Release of Full Financial Results for the Fourth Quarter and Fiscal Year Ended September...
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
WEST LAFAYETTE, Ind., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...
Inotiv, Inc. Announces Additional Site Consolidation Plan in the U.S., Intent to Consult with Employee Representatives for a Proposed Consolidation of Certain European and U.K. Sites, and Update on Site Optimization Plans in Process
WEST LAFAYETTE, Ind., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...
Inotiv, Inc. to Report Fourth Quarter Fiscal 2022 Financial Results and Host Conference Call on Monday, December 12, 2022
WEST LAFAYETTE, Ind., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...
Inotiv, Inc. to Participate in November Investor Conferences
WEST LAFAYETTE, Ind., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...
Inotiv, Inc. to Participate in September Investor Conferences
WEST LAFAYETTE, Ind., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...
Inotiv Investor Alert
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inotiv To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Co...